Cancer
by Kyra E. Cappelucci | Jul 1, 2016 | Commentary, Perspectives
Now in its third year of data disclosure, the Physician Payments Sunshine Act has helped demystify financial connections between two critically linked health sector stakeholders: health care providers and pharmaceutical companies. This week, the 2015 figures...
by Straton Mwashighadi | Feb 19, 2015 | Discussion Paper, Perspectives
The types of evidence needed to support the use of genome sequencing in the clinic varies by stakeholder and circumstance. In this IOM series, seven individually authored commentaries explore this important issue, discussing the challenges involved in and...
by Keenan Faulkner | Oct 5, 2012 | Commentary, Perspectives
My story of innovation begins in 1981, when, as a young surgical trainee in Boston, I was shocked to learn that my dreams of joining the pioneers in the exciting new field of heart transplantation had been abruptly shattered—by a policy decision. The trustees of the...
by Denise Walker | May 11, 2012 | Discussion Paper, Perspectives
Statement of Purpose Rapid, seamless data exchange in cancer—throughout the continuum from research to clinical care—remains an unmet need with no clear path forward to a solution. We assert that there is a national urgency to find solutions to support and sustain the...
